BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 30321569)

  • 21. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.
    Rajagopal R; Harbour JW
    Retina; 2011 Mar; 31(3):435-40. PubMed ID: 21336066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraocular chemotherapy for vitreoretinal lymphoma: A review.
    Kvopka M; Lake SR; Smith JR
    Clin Exp Ophthalmol; 2020 Mar; 48(2):240-248. PubMed ID: 31680408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
    Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
    Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How we diagnose and treat vitreoretinal lymphoma.
    Fend F; Ferreri AJ; Coupland SE
    Br J Haematol; 2016 Jun; 173(5):680-92. PubMed ID: 27133587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
    Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
    Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case of extranodal natural killer/T-cell lymphoma, nasal type, accompanied by Epstein-Barr virus-positive nasopharyngeal carcinoma.
    Senda N; Miyagaki T; Oka T; Itoigawa A; Kikuchi K; Kobayashi T; Nakamura F; Kurokawa M; Sugaya M; Sato S
    J Dermatol; 2019 May; 46(5):e161-e163. PubMed ID: 30379350
    [No Abstract]   [Full Text] [Related]  

  • 28. AN UNUSUAL CASE OF PRIMARY VITREORETINAL LYMPHOMA: A TRANSFORMED LYMPHOMA.
    Ustaoglu M; Patel R; Wang W; Shah S; Barr C
    Retin Cases Brief Rep; 2024 Mar; 18(2):181-183. PubMed ID: 36730965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraocular Lymphoma: Descriptive Data of 26 Patients Including Clinico-pathologic Features, Vitreous Findings, and Treatment Outcomes.
    Abu Samra K; Oray M; Ebrahimiadib N; Lee S; Anesi S; Foster CS
    Ocul Immunol Inflamm; 2018; 26(3):347-352. PubMed ID: 27438792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of primary cutaneous extranodal natural killer/t-cell lymphoma, nasal type, with a 22-year indolent clinical course.
    Zuriel D; Fink-Puches R; Cerroni L
    Am J Dermatopathol; 2012 Apr; 34(2):194-7. PubMed ID: 22172956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Vitreoretinal Lymphoma in HIV Infection.
    Steffen J; Coupland SE; Smith JR
    Ocul Immunol Inflamm; 2021 Apr; 29(3):621-627. PubMed ID: 32453669
    [No Abstract]   [Full Text] [Related]  

  • 32. PRESUMPTIVE RECURRENCE OF INTRAOCULAR LYMPHOMA DESPITE CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY.
    Taher A; Abadir E; McCluskey P; Hamad N; Lo TH; Heydon P
    Retin Cases Brief Rep; 2023 Sep; 17(5):562-566. PubMed ID: 37643043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary Vitreoretinal Lymphoma Masquerading as Acute Retinal Necrosis.
    Ryan ME; Shantha JG; Grossniklaus HE; Yeh S
    Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):1048-50. PubMed ID: 26599249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
    Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
    Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytologic features in vitreous preparations of patients with suspicion of intraocular lymphoma.
    Rodriguez EF; Sepah YJ; Jang HS; Ibrahim M; Nguyen QD; Rodriguez FJ
    Diagn Cytopathol; 2014 Jan; 42(1):37-44. PubMed ID: 24167062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
    Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
    JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal Melphalan for Treatment of Primary Vitreoretinal Lymphoma: A New Indication for an Old Drug.
    Shields CL; Sioufi K; Mashayekhi A; Shields JA
    JAMA Ophthalmol; 2017 Jul; 135(7):815-818. PubMed ID: 28617918
    [No Abstract]   [Full Text] [Related]  

  • 38. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
    Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
    Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYSTOID MACULAR EDEMA IN THE SETTING OF PRIMARY VITREORETINAL LYMPHOMA.
    Deák GG; Sneed SR; Jampol LM
    Retin Cases Brief Rep; 2021 Mar; 15(2):104-106. PubMed ID: 30015778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.